Zevra Therapeutics (ZVRA) Inventory Average (2025 - 2026)
Zevra Therapeutics' (ZVRA) quarterly Inventory Average came in at $2.0 million in Q1 2026, down 10.58% YoY from $2.3 million in Q1 2025, and up 30.35% on a QoQ basis from $1.6 million in Q4 2025.
Zevra Therapeutics (ZVRA) Inventory Average (2025 - 2026) Analysis & Trends
Zevra Therapeutics (ZVRA) has 2 years of Inventory Average data on file, last reported at $2.0 million in Q1 2026.
- Quarterly Inventory Average fell 10.58% year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 million (down 10.58% YoY) and the FY2025 annual result came in at $1.9 million, changed N/A from the prior year.
- Inventory Average advanced to $2.0 million in Q1 2026, from $1.6 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $2.3 million in Q1 2025 to a low of $1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Zevra Therapeutics | 671.75 Mn | 450.18 Mn | 38.18 Mn | 2.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.38 Mn |
| Mar 31, 2026 | 2.03 Mn |
| Dec 31, 2025 | 1.55 Mn |
| Sep 30, 2025 | 1.24 Mn |
| Jun 30, 2025 | 1.83 Mn |
| Mar 31, 2025 | 2.26 Mn |